Malango T Msukwa1,2, Janne Estill1,3, Andreas D Haas4, Joep J van Oosterhout5,6, Lyson Tenthani4,7, Mary-Ann Davies8, Kali Tal1,9, Nozgechi Phiri1,2, Adrian Spoerri4, Bryan C Mthiko1,2, Frank Chimbwandira10, Olivia Keiser1. 1. Institute of Global Health, University of Geneva, Geneva, Switzerland. 2. Baobab Health Trust, Lilongwe, Malawi. 3. Institute of Mathematical Statistics and Actuarial Science. 4. Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. 5. Dignitas International, Zomba, Malawi. 6. Department of Medicine, College of Medicine, University of Malawi. 7. Project SOAR, Population Council, Blantyre, Malawi. 8. Centre of Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa. 9. Institute of Primary Healthcare, University of Bern, Bern, Switzerland. 10. Ministry of Health, Lilongwe, Malawi.
Abstract
OBJECTIVE: To compare birth weight and weight gain in HIV-exposed, uninfected (HEU) infants up to 24 months old, who enrolled in the Malawian national HIV care clinic (HCC) programme either before or after Option B+ (OB+) was implemented. DESIGN, SETTING AND PARTICIPANTS: HIV-exposed infants enrol in the HCC programme as soon as possible after birth and are followed up to at least 24 months old. This analysis includes HEU infants with recorded birth weight, date of birth, gender and at least one follow-up weight measurement from 21 health facilities in central and southern Malawi (January 2010-December 2014). Weight-for-age z scores (WAZ) were derived and compared by birth period using linear regression at birth and mixed effects models for postnatal weight gain up to 24 months old. RESULTS: Of 6845 HEU infants included in this study, 88.5% were born after OB+. The proportion of infants exposed in utero to combination antiretroviral therapy (ART) significantly increased after OB+ was implemented, and infants were exposed to ART for a longer time. There was no significant difference in WAZ at birth (P = 0.654) among HEU infants by birth period, but postnatal weight gain was faster among HEU infants born in the Option B+ period than infants born pre-Option B+. CONCLUSION: Birth weight was not affected by longer exposure to ART during pregnancy after OB+ was introduced, when weight gain in HEU infants was faster, possibly because their mothers were in better health.
OBJECTIVE: To compare birth weight and weight gain in HIV-exposed, uninfected (HEU) infants up to 24 months old, who enrolled in the Malawian national HIV care clinic (HCC) programme either before or after Option B+ (OB+) was implemented. DESIGN, SETTING AND PARTICIPANTS: HIV-exposed infants enrol in the HCC programme as soon as possible after birth and are followed up to at least 24 months old. This analysis includes HEU infants with recorded birth weight, date of birth, gender and at least one follow-up weight measurement from 21 health facilities in central and southern Malawi (January 2010-December 2014). Weight-for-age z scores (WAZ) were derived and compared by birth period using linear regression at birth and mixed effects models for postnatal weight gain up to 24 months old. RESULTS: Of 6845 HEU infants included in this study, 88.5% were born after OB+. The proportion of infants exposed in utero to combination antiretroviral therapy (ART) significantly increased after OB+ was implemented, and infants were exposed to ART for a longer time. There was no significant difference in WAZ at birth (P = 0.654) among HEU infants by birth period, but postnatal weight gain was faster among HEU infants born in the Option B+ period than infants born pre-Option B+. CONCLUSION: Birth weight was not affected by longer exposure to ART during pregnancy after OB+ was introduced, when weight gain in HEU infants was faster, possibly because their mothers were in better health.
Authors: Kathleen M Powis; Laura Smeaton; Anthony Ogwu; Shahin Lockman; Scott Dryden-Peterson; Erik van Widenfelt; Jean Leidner; Joseph Makhema; Max Essex; Roger L Shapiro Journal: J Acquir Immune Defic Syndr Date: 2011-02-01 Impact factor: 3.731
Authors: Kartik K Venkatesh; Mark N Lurie; Elizabeth W Triche; Guy De Bruyn; Joseph I Harwell; Stephen T McGarvey; Glenda E Gray Journal: Trop Med Int Health Date: 2010-11 Impact factor: 2.622
Authors: Jennifer Y Chen; Heather J Ribaudo; Sajini Souda; Natasha Parekh; Anthony Ogwu; Shahin Lockman; Kathleen Powis; Scott Dryden-Peterson; Tracy Creek; William Jimbo; Tebogo Madidimalo; Joseph Makhema; Max Essex; Roger L Shapiro Journal: J Infect Dis Date: 2012-10-12 Impact factor: 5.226
Authors: Karin van der Merwe; Risa Hoffman; Vivian Black; Matthew Chersich; Ashraf Coovadia; Helen Rees Journal: J Int AIDS Soc Date: 2011-08-15 Impact factor: 5.396
Authors: Sally Grantham-McGregor; Yin Bun Cheung; Santiago Cueto; Paul Glewwe; Linda Richter; Barbara Strupp Journal: Lancet Date: 2007-01-06 Impact factor: 79.321
Authors: Anne Esther Njom Nlend; Annie Nga Motazé; Suzie Moyo Tetang; Cécile Zeudja; Marcus Ngantcha; Mathurin Tejiokem Journal: PLoS One Date: 2016-03-21 Impact factor: 3.240
Authors: Malango T Msukwa; Olivia Keiser; Andreas Jahn; Joep J van Oosterhout; Andrew Edmonds; Nozgechi Phiri; Ronald Manjomo; Mary-Ann Davies; Janne Estill Journal: Trop Med Int Health Date: 2019-04-01 Impact factor: 2.622
Authors: Dorothy C Nyemba; Emma Kalk; Michael J Vinikoor; Hlengiwe P Madlala; Mwangelwa Mubiana-Mbewe; Maureen Mzumara; Carolyn Bolton Moore; Amy L Slogrove; Andrew Boulle; Mary-Ann Davies; Landon Myer; Kathleen Powis Journal: BMC Public Health Date: 2022-01-10 Impact factor: 4.135
Authors: Andrew Edmonds; Ellen Brazier; Beverly S Musick; Marcel Yotebieng; John Humphrey; Lisa L Abuogi; Adebola Adedimeji; Olivia Keiser; Malango Msukwa; James G Carlucci; Marcelle Maia; Jorge A Pinto; Valériane Leroy; Mary-Ann Davies; Kara K Wools-Kaloustian Journal: PLoS Med Date: 2022-09-15 Impact factor: 11.613